−0.38USD
−13.34 MUSD
36.08 MUSD
17.21 M
About Equillium, Inc.
Sector
Industry
CEO
Bruce D. Steel
Website
Headquarters
La Jolla
Employees (FY)
44
Founded
2017
FIGI
BBG00LSL8C10
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March, 2017 and is headquartered in La Jolla, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EQ is 1.65 USD — it has increased by 2.48% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Equillium, Inc. stocks are traded under the ticker EQ.
Equillium, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
EQ stock is 8.52% volatile and has beta coefficient of 0.72. Check out the list of the most volatile stocks — is Equillium, Inc. there?
EQ earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.18 USD resulting in a 38.89% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Equillium, Inc. earnings.
Equillium, Inc. revenue for the last quarter amounts to 8.87 M USD despite the estimated figure of 6.43 M USD. In the next quarter revenue is expected to reach 6.43 M USD.
Yes, you can track Equillium, Inc. financials in yearly and quarterly reports right on TradingView.
EQ stock has fallen by 12.70% compared to the previous week, the month change is a 39.34% fall, over the last year Equillium, Inc. has showed a 139.13% increase.
EQ net income for the last quarter is −2.34 M USD, while the quarter before that showed −3.71 M USD of net income which accounts for 36.87% change. Track more Equillium, Inc. financial stats to get the full picture.
Today Equillium, Inc. has the market capitalization of 58.17 M, it has decreased by 16.22% over the last week.
No, EQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Equillium, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 44.00 employees. See our rating of the largest employees — is Equillium, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Equillium, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Equillium, Inc. stock shows the neutral signal. See more of Equillium, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Equillium, Inc. future price: according to them, EQ price has a max estimate of 8.00 USD and a min estimate of 5.00 USD. Read a more detailed Equillium, Inc. forecast: see what analysts think of Equillium, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Equillium, Inc. EBITDA is −14.40 M USD, and current EBITDA margin is −39.90%. See more stats in Equillium, Inc. financial statements.